<DOC>
	<DOCNO>NCT02679807</DOCNO>
	<brief_summary>This randomize , double-blind placebo control trial evaluate effect probiotic ( Bl-04 ) occurrence rhinovirus-associated common cold illness experimental rhinovirus challenge model . A previous study document Bl-04 significant effect innate immune response nose study power ass whether effect translate demonstrable clinical benefit . Volunteers give Bl-04 placebo 28 day challenge rhinovirus . The primary analysis proportion volunteer develop rhinovirus associate illness two treatment group .</brief_summary>
	<brief_title>Effect Probiotic Rhinovirus Induced Colds</brief_title>
	<detailed_description />
	<mesh_term>Common Cold</mesh_term>
	<criteria>INCLUSION CRITERIA AT ENROLLMENT : Subject must 1860 year age . Subject must read sign copy approve Consent Form Subject must serum neutralize antibody titer le equal 1:4 rhinovirus type 39 INCLUSION CRITERIA AT DAY 28 â€¢ Female subject must use effective birth control method . INCLUSION CRITERIA AT CHALLENGE : Female subject must use effective birth control method . Antibiotic use within 3 month prior day 28 Female subject positive urine pregnancy screen History use probiotic precede two week Current cancer diagnosis immunosuppressive therapy last 6 month Any clinically significant abnormality upper respiratory tract Any clinically significant acute chronic respiratory illness Any clinically significant bleeding tendency history Hypertension require treatment antihypertensive medication History angina clinically significant cardiac disease Any medical condition opinion Principal Investigator cause exclusion study History regular use ( 3 day 7 ) tobacco product within precede two week History drug alcohol abuse 6 month precede study EXCLUSION CRITERIA AT CHALLENGE : Any upper respiratory infection allergic rhinitis two week prior challenge Female subject positive pregnancy screen prior challenge Any medical condition opinion Principal Investigator cause exclusion study Use antiinflammatory ( steroids NSAIDs ) cough/cold allergy preparation two week prior challenge</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>